| Literature DB >> 26959036 |
Liu-Qiang Zhang1, Xiao-Chong Chen2, Zhao-Qiang Chen3, Gui-Min Wang4, Shi-Guo Zhu5, Yi-Fu Yang6, Kai-Xian Chen7,8, Xiao-Yu Liu9, Yi-Ming Li10.
Abstract
Eutypenoids A-C (1-3), pimarane diterpenoid alkaloid and two ring A rearranged pimarane diterpenoids, were isolated from the culture of Eutypella sp. D-1 obtained from high-latitude soil of the Arctic. Their structures, including absolute configurations, were authenticated on the basis of the mass spectroscopy (MS), nuclear magnetic resonance (NMR), X-ray crystallography, and electronic circular dichroism (ECD) analysis. The immunosuppressive effects of eutypenoids A-C (1-3) were studied using a ConA-induced splenocyte proliferation model, which suggested that 2 exhibited potent immunosuppressive activities.Entities:
Keywords: Arctic fungi; Eutypella; eutypenoid; immunosuppressive effect; novel pimarane diterpenes
Mesh:
Substances:
Year: 2016 PMID: 26959036 PMCID: PMC4820298 DOI: 10.3390/md14030044
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–3.
Figure 21H-1H COSY, HMBC correlations of eutyenoids A–C (1–3).
Figure 3Key NOESY correlations of eutyenoids A–C (1–3).
Figure 4X-ray crystallographic structure of eutyenoid A (1).
1H and 13C NMR data of eutypenoids A–C (1–3) in CDCl3.
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| 1 | 67.2, CH2 | 3.71, d (13.1) | 132.2, CH | 6.15, dd (3.3, 9.5) | 28.7, CH | 2.88, m |
| 2.90, t (12.3) | ||||||
| 2 | 27.6, CH2 | 1.97, m | 127.8, CH | 6.02, m | 25.7, CH2 | 2.15, m 1.45, m |
| 1.58, m | ||||||
| 3 | 40.6, CH2 | 1.66, m | 39.6, CH2 | 2.47, d (16.0) | 72.8, CH | 5.20, d (2.7) |
| 2.05, dd (7.7, 16.0) | ||||||
| 4 | 49.8, C | 38.3, C | 41.3, C | |||
| 5 | 138.6, C | 146.6, C | 122.7, C | |||
| 6 | 149.3, C | 143.0, C | 143.3, C | |||
| 7 | 179.0, C | 181.3, C | 142.3, C | |||
| 8 | 129.6, C | 133.6, C | 119.2, C | |||
| 9 | 148.8, C | 153.0, C | 124.7, C | |||
| 10 | 76.9, C | 44.8, C | 126.2, C | |||
| 11 | 124.1, CH | 7.54, d (8.0) | 153.5, C | 66.5, CH | 4.60, dd (6.2, 10.6) | |
| 12 | 135.0, CH | 7.43, d (8.0) | 28.7, CH2 | 2.86, s | 42.6, CH2 | 2.18, m 1.72, m |
| 13 | 136.5, C | 39.7, C | 43.3, C | |||
| 14 | 140.6, C | 69.8, CH | 4.68, s | 76.5, CH | 4.82, s | |
| 15 | 137.1, CH | 7.19, dd (11.5, 18.0) | 142.4, CH | 6.06, dd (18.0, 10.8) | 138.2, CH | 5.92, dd (10.7, 17.7) |
| 16 | 117.0, CH2 | 5.49, d (11.5) | 114.4, CH2 | 5.20, d (18.0) | 119.8, CH2 | 5.36, d (10.7) |
| 5.06, d (18.0) | 5.17, d (10.8) | 5.33, d (17.7) | ||||
| 17 | 21.4, CH3 | 2.37, s | 23.9, CH3 | 1.05, s | 23.5, CH3 | 1.31, s |
| 18 | 20.1, CH3 | 1.47, s | 27.9, CH3 | 1.28, s | 66.3, CH2 | 5.16, d (10.7) |
| 4.31, d (10.7) | ||||||
| 19 | 83.4, CH2 | 4.22, d (8.6) | 27.4, CH3 | 1.53, s | 22.1, CH3 | 1.45, s |
| 4.11, d (8.6) | ||||||
| 20 | 33.1, CH3 | 1.60, s | 27.0, CH3 | 1.62, s | 68.6, CH2 | 4.05, dd (6.5, 8.9) |
| 3.10, dd (8.9, 10.8) | ||||||
| 6-OH/21 | 6.76, s | 170.6, C | ||||
| N-OH/22 | 7.94, s | 21.4, CH3 | 1.97, s | |||
| 23 | 177.1, C | |||||
| 24 | 34.4, CH | 2.53, sep (7.0) | ||||
| 25 | 19.1, CH3 | 1.14, d (7.0) | ||||
| 26 | 19.2, CH3 | 1.12, d (7.0) | ||||
a In CDCl3 (100 MHz); b In CDCl3 (400 MHz); c In CDCl3 (150 MHz); d In CDCl3 (600 MHz).
Figure 5Comparison of experimental and calculated ECD spectra of 2 (A) and 3 (B). Geometries optimization were performed at theB3LYP/6-31G(d) level and ECD calculation were performed at the B3LYP/6-31G(d,p) level in methanol with the CPCM model.
Figure 6Cytotoxicity on splenocytes and inhibition on ConA-induced splenocyte proliferation of compounds 1–3. (a) Cytotoxicity of compounds 1–3 on BALB/c mice splenocytes. The cells were incubated with different concentration of compounds 1–3 for 48 h. MTT was then added to the medium (0.5 mg/mL) and incubated for 4 h before the end of the incubation period. The cell viability was tested through the relative formazan concentration measured by the optical density at 570 nm (OD570 nm) using a microplate reader. (b) Inhibition of compounds 1–3 on ConA-induced splenocyte proliferation. BALB/c mice splenocytes (4 × 105 cells/well) were stimulated by ConA (2 μg/mL) for 48 h in the presence of different compounds 1–3. Cells were then pulsed with 0.25 μCi [3H]-thymidine 8 h before the end of the experiment and were assessed for [3H]-thymidine incorporation by counts per minute (cpm). Results are mean ± S.D. ∗ p < 0.05, ∗∗ p < 0.01, treatment group versus control.